1
|
Houlihan I, Kang B, Krishna V, De S. Proof-of-concept for a novel nanotechnology-based treatment for urolithiasis. Urolithiasis 2024; 52:60. [PMID: 38581591 PMCID: PMC10998784 DOI: 10.1007/s00240-024-01564-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2023] [Accepted: 03/22/2024] [Indexed: 04/08/2024]
Abstract
Proof-of-concept of photonic lithotripsy in an in vitro setting and its ability to fragment the most common stone types is demonstrated. Effectiveness of different classes of photonic nanoparticles in fragmenting human stones is assessed. De-identified human stones were collected after institutional approval. Stones of a size range between 2-4 mm were rehydrated in simulated urine for 24 h. Stones were then coated with a solution of nanoparticles prior to activation with either a 785 nm or 1320 nm near-infrared energy source. Photonic lithotripsy achieved greater than 70% success rate in fragmentating calcium oxalate monohydrate stones using carbon-based nanoparticles for both near-infrared wavelengths. For gold-based nanoparticles, there was a similar success rate with the 785 nm wavelength but a significant decrease when using the 1320 nm wavelength energy source. All stones fragmented with the energy source at a distance ≥ 20 mm from the stone's surface. Limitations include the use of mixed-composition stones, a lack of complete stone immersion in liquid during treatment, and smaller stone size. Different classes of nanoparticles when excited with a near-infrared energy source can fragment common stone types in vitro. This technology has the potential to change the way we approach and treat patients with urolithiasis in a clinical setting.
Collapse
Affiliation(s)
- Ian Houlihan
- Biomedical Engineering Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA
| | - Benjamin Kang
- Biomedical Engineering Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA
| | - Vijay Krishna
- Biomedical Engineering Department, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
- Biomedical Engineering Department, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
| | - Smita De
- Urology Department, Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
- Urology Department, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA.
| |
Collapse
|
2
|
Beyk J, Tavakoli H. Selective radiofrequency ablation of tumor by magnetically targeting of multifunctional iron oxide-gold nanohybrid. J Cancer Res Clin Oncol 2019; 145:2199-2209. [PMID: 31309302 DOI: 10.1007/s00432-019-02969-1] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/25/2019] [Accepted: 07/01/2019] [Indexed: 01/16/2023]
Abstract
PURPOSE Radiofrequency (RF) ablation therapy is of great interest in cancer therapy as it is non-ionizing radiation and can effectively penetrate into the tissue. However, the current RF ablation technique is invasive that requires RF probe insertion into the tissue and generates a non-specific heating. Recently, RF-responsive nanomaterials such as gold nanoparticles (AuNPs) and iron oxide nanoparticles (IONPs) have led to tremendous progress in this area. They have been found to be able to absorb the RF field and induce a localized heating within the target, thereby affording a non-invasive and tumor-specific RF ablation strategy. In the present study, for the first time, we used a hybrid core-shell nanostructure comprising IONPs as the core and AuNPs as the shell (IO@Au) for targeted RF ablation therapy. Due to the magnetic core, the nanohybrid can be directed toward the tumor through a magnet. Moreover, IONPs enable the nanohybrid to be used as a magnetic resonance imaging (MRI) contrast agent. RESULTS In vitro cytotoxicity experiment showed that the combination of IO@Au and 13.56-MHz RF field significantly reduced the viability of cancer cells. Next, during an in vivo experiment, we demonstrated that magnetically targeting of IO@Au to the tumor and subsequent RF exposure dramatically suppressed the tumor growth. CONCLUSION Therefore, the integration of targeting, imaging, and therapeutic performances into IO@Au nanohybrid could afford the promise to improve the effectiveness of RF ablation therapy.
Collapse
Affiliation(s)
- Jaber Beyk
- Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
| | - Hassan Tavakoli
- Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran. .,Department of Physiology and Biophysics, Baqiyatallah University of Medical Sciences, Tehran, Iran.
| |
Collapse
|
3
|
Postnikov AV, Moldosanov KA. Suggested design of gold-nanoobjects-based terahertz radiation source for biomedical research. NANOTECHNOLOGY 2018; 29:285704. [PMID: 29667938 DOI: 10.1088/1361-6528/aabf10] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Gold nanoparticles (GNPs) may serve as devices to emit electromagnetic radiation in the terahertz (THz) range, whereby the energy is delivered by radio frequency or microwave photons which will not by themselves induce transitions between sparse confinement-shaped electron levels of a GNP, but may borrow the energy from longitudinal acoustic (LA) phonons to overcome the confinement gap. Upon excitation, the Fermi electron cannot relax otherwise than via emitting a THz photon, the other relaxation channels being blocked by force of shape and size considerations. Within this general scope that has already been outlined earlier, the present work specifically discusses two-phonon processes, namely (i) a combined absorption-emission of two phonons from the top of the LA branch, and (ii) an absorption of two such phonons with nearly identical wavevectors. The case (i) may serve as a source of soft THz radiation (at ≃0.54 THz), the case (ii) the hard THz radiation at 8.7 THz. Numerical estimates are done for crystalline particles in the shape of rhombicuboctahedra, of 5-7 nm size. A technical realisation of this idea is briefly discussed, assuming the deposition of GNPs onto/within the substrate of Teflon®, the material sustaining high temperatures and transparent in the THz range.
Collapse
Affiliation(s)
- A V Postnikov
- Université de Lorraine, LCP-A2MC, 1 Bd Arago, F-57078 Metz, France
| | | |
Collapse
|
5
|
Letfullin RR, George TF. Nanotherapy of cancer by photoelectrons emitted from the surface of nanoparticles exposed to nonionizing ultraviolet radiation. Nanomedicine (Lond) 2017; 12:1107-1117. [PMID: 28447907 DOI: 10.2217/nnm-2017-0053] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
AIM We introduce a new method for selectively destroying cancer cell organelles by electrons emitted from the surface of intracellularly localized nanoparticles exposed to the nonionizing ultraviolet (UV) radiation. METHODS We propose to target cancerous intracellular organelles by nanoparticles and expose them to UV radiation with energy density safe for healthy tissue. RESULTS We simulate the number of photoelectrons produced by the nanoparticles made of various metals and radii, calculate their kinetic energy and compare it to the threshold energy for producing biological damage. CONCLUSION Exposure of metal nanoparticles to UV radiation generates photoelectrons with kinetic energies up to 11 eV, which is high enough to produce single- to double-strand breaks in the DNA and damage the cancerous cell organelles.
Collapse
Affiliation(s)
- Renat R Letfullin
- Department of Physics & Optical Engineering, Rose-Hulman Institute of Technology, 5500 Wabash Ave, Terre Haute, IN 47803, USA
| | - Thomas F George
- Office of the Chancellor & Center for Nanoscience, Departments of Chemistry/Biochemistry & Physics/Astronomy, University of Missouri-St. Louis, St. Louis, MO 63121, USA
| |
Collapse
|
7
|
Corr SJ, Shamsudeen S, Vergara LA, Ho JCS, Ware MJ, Keshishian V, Yokoi K, Savage DJ, Meraz IM, Kaluarachchi W, Cisneros BT, Raoof M, Nguyen DT, Zhang Y, Wilson LJ, Summers H, Rees P, Curley SA, Serda RE. A New Imaging Platform for Visualizing Biological Effects of Non-Invasive Radiofrequency Electric-Field Cancer Hyperthermia. PLoS One 2015; 10:e0136382. [PMID: 26308617 PMCID: PMC4550384 DOI: 10.1371/journal.pone.0136382] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/03/2014] [Accepted: 08/03/2015] [Indexed: 12/25/2022] Open
Abstract
Herein, we present a novel imaging platform to study the biological effects of non-invasive radiofrequency (RF) electric field cancer hyperthermia. This system allows for real-time in vivo intravital microscopy (IVM) imaging of radiofrequency-induced biological alterations such as changes in vessel structure and drug perfusion. Our results indicate that the IVM system is able to handle exposure to high-power electric-fields without inducing significant hardware damage or imaging artifacts. Furthermore, short durations of low-power (< 200 W) radiofrequency exposure increased transport and perfusion of fluorescent tracers into the tumors at temperatures below 41°C. Vessel deformations and blood coagulation were seen for tumor temperatures around 44°C. These results highlight the use of our integrated IVM-RF imaging platform as a powerful new tool to visualize the dynamics and interplay between radiofrequency energy and biological tissues, organs, and tumors.
Collapse
Affiliation(s)
- Stuart J. Corr
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
- Department of Chemistry, Rice University, Houston, TX, United States of America
- Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America
| | - Sabeel Shamsudeen
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
- Department of Biomedical Engineering, University of Houston, TX, United States of America
| | - Leoncio A. Vergara
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
| | - Jason Chak-Shing Ho
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
| | - Matthew J. Ware
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
| | - Vazrik Keshishian
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
| | - Kenji Yokoi
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
| | - David J. Savage
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
| | - Ismail M. Meraz
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
| | - Warna Kaluarachchi
- Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America
| | - Brandon T. Cisneros
- Department of Chemistry, Rice University, Houston, TX, United States of America
- Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America
| | - Mustafa Raoof
- Department of Surgical Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, United States of America
| | - Duy Trac Nguyen
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
- Department of Biomedical Engineering, University of Houston, TX, United States of America
| | - Yingchun Zhang
- Department of Biomedical Engineering, University of Houston, TX, United States of America
| | - Lon J. Wilson
- Department of Chemistry, Rice University, Houston, TX, United States of America
| | - Huw Summers
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
- Centre for Nanohealth, College of Engineering, Swansea University, Swansea, Wales, United Kingdom
| | - Paul Rees
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
- Centre for Nanohealth, College of Engineering, Swansea University, Swansea, Wales, United Kingdom
- The Broad Institute, Cambridge, MA, United States of America
| | - Steven A. Curley
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
- Department of Mechanical Engineering and Materials Science, Rice University, Houston, TX, United States of America
| | - Rita E. Serda
- Department of Surgery, Division of Surgical Research, Baylor College of Medicine, Houston, TX, United States of America
- Department of Nanomedicine, Houston Methodist Research Institute, Houston, TX, United States of America
| |
Collapse
|